CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

Cash flow Chongqing Zhifei Biological Products Co., Ltd.

Equities

300122

CNE100000V20

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-07-14			5-day change	1st Jan Change
20.32 ^CNY	-1.07%		+4.53%	-22.74%

06-06	Zhifei Biological Products' Pneumonia Vaccine Enters Production Registration Review	MT
06-03	Chinese Drug Regulator Accepts Chongqing Zhifei Biological Products' Application to Produce Meningococcal Vaccine	MT

ae402f0257bd511634f639c632eb.OxS-PztPy9ABXTfKX6SLIWPf_1-AyMgyIKDHhrGKjok.VFDccmkh_LJWZWO7bc_hdgm9zRyzpJ90f9e36Oa86cBtTPFrXBb5o0Aqcg

Published financial data: CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	15.16B	30.63B	38.26B	52.91B	25.85B
Other Revenues, Total	34.23M	23.46M	3.85M	4.08M	223M
Total Revenues	15.19B	30.65B	38.26B	52.92B	26.07B
Cost of Goods Sold, Total	9.32B	15.71B	25.52B	39B	18.97B
Gross Profit	5.87B	14.94B	12.75B	13.92B	7.1B
Selling General & Admin Expenses, Total	1.41B	2.14B	2.6B	3.16B	3.04B
Provision for Bad Debts	82.93M	191M	421M	353M	609M
R&D Expenses	300M	553M	854M	968M	971M
Other Operating Expenses	70.99M	135M	177M	239M	135M
Other Operating Expenses, Total	1.86B	3.01B	4.05B	4.72B	4.76B
Operating Income	4.01B	11.92B	8.7B	9.21B	2.34B
Interest Expense, Total	-127M	-56.14M	-53.3M	-81M	-147M
Interest And Investment Income	11.98M	61.47M	46.09M	67.94M	66.63M
Net Interest Expenses	-115M	5.33M	-7.2M	-13.05M	-80.23M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	3.84M	-10.1M	15.4M	2.28M	1.67M
Other Non Operating Income (Expenses)	-19.61M	-17.23M	-22.64M	-36.56M	-37.32M
EBT, Excl. Unusual Items	3.88B	11.9B	8.68B	9.16B	2.22B
Gain (Loss) On Sale Of Investments	-13.33M	-5.63M	-	-	-
Gain (Loss) On Sale Of Assets	19.65K	39.13K	6.69K	41.37M	46.95K
Asset Writedown	-549K	-1.68M	-92.8K	-129K	-362K
Other Unusual Items	-12.36M	35.83M	34.31M	142M	32.05M
EBT, Incl. Unusual Items	3.85B	11.93B	8.72B	9.34B	2.25B
Income Tax Expense	553M	1.72B	1.18B	1.27B	235M
Earnings From Continuing Operations	3.3B	10.21B	7.54B	8.07B	2.02B
Net Income to Company	3.3B	10.21B	7.54B	8.07B	2.02B
Net Income - (IS)	3.3B	10.21B	7.54B	8.07B	2.02B
Net Income to Common Incl Extra Items	3.3B	10.21B	7.54B	8.07B	2.02B
Net Income to Common Excl. Extra Items	3.3B	10.21B	7.54B	8.07B	2.02B
Per Share Items
Net EPS - Basic	1.38	4.25	3.14	3.36	0.84
Basic EPS - Continuing Operations	1.38	4.25	3.14	3.36	0.84
Basic Weighted Average Shares Outstanding	2.4B	2.4B	2.4B	2.4B	2.4B
Net EPS - Diluted	1.38	4.25	3.14	3.36	0.84
Diluted EPS - Continuing Operations	1.38	4.25	3.14	3.36	0.84
Diluted Weighted Average Shares Outstanding	2.4B	2.4B	2.4B	2.4B	2.4B
Normalized Basic EPS	1.01	3.1	2.26	2.39	0.58
Normalized Diluted EPS	1.01	3.1	2.26	2.39	0.58
Dividend Per Share	0.33	0.4	0.33	0.8	0.2
Payout Ratio	28.13	8.44	13.46	11.02	125.23
Supplemental Items
EBITDA	4.13B	12.3B	9B	9.51B	2.71B
EBITA	4.02B	12.04B	8.74B	9.22B	2.36B
EBIT	4.01B	11.92B	8.7B	9.21B	2.34B
EBITDAR	4.14B	12.3B	9.01B	9.59B	2.79B
Total Revenues (As Reported)	15.19B	30.65B	38.26B	52.92B	26.07B
Effective Tax Rate - (Ratio)	14.34	14.44	13.52	13.62	10.44
Current Domestic Taxes	597M	1.7B	1.24B	1.66B	608M
Total Current Taxes	597M	1.7B	1.24B	1.66B	608M
Deferred Domestic Taxes	-44.52M	27.28M	-58.31M	-386M	-373M
Total Deferred Taxes	-44.52M	27.28M	-58.31M	-386M	-373M
Normalized Net Income	2.43B	7.44B	5.43B	5.72B	1.39B
Interest Capitalized	-	1.22M	322K	-	-
Interest on Long-Term Debt	-	-	-	1.38M	1.23M
Non-Cash Pension Expense	1.79M	2.75M	3.12M	3.22M	4.56M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	476M	395M
Marketing Expenses	371M	550M	641M	290M	261M
Selling and Marketing Expenses	1.2B	1.83B	2.24B	2.77B	2.65B
General and Administrative Expenses	212M	300M	360M	383M	394M
Research And Development Expense From Footnotes	302M	651M	881M	978M	986M
Net Rental Expense, Total	6.14M	8.81M	9.35M	75.25M	78.64M
Imputed Operating Lease Interest Expense	2.38M	2.19M	2.81M	19.24M	12M
Imputed Operating Lease Depreciation	3.77M	6.62M	6.53M	56.01M	66.63M
Maintenance & Repair Expenses, Total	-	-	13.98M	10.38M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.44B	4.31B	2.62B	6.34B	2.7B
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	1.44B	4.31B	2.62B	6.34B	2.7B
Accounts Receivable, Total	6.62B	12.87B	20.61B	27.06B	16.27B
Other Receivables	9.07M	6.87M	8.39M	7.8M	10.95M
Total Receivables	6.63B	12.87B	20.62B	27.07B	16.28B
Inventory	3.41B	7.39B	8.02B	8.99B	22.22B
Prepaid Expenses	-	588K	45.39M	-	8.11M
Other Current Assets, Total	60.71M	186M	103M	121M	82.61M
Total Current Assets	11.54B	24.75B	31.41B	42.51B	41.29B
Gross Property Plant And Equipment	2.82B	4.26B	5.66B	6.39B	7.02B
Accumulated Depreciation	-438M	-699M	-968M	-1.26B	-1.65B
Net Property Plant And Equipment	2.39B	3.56B	4.69B	5.12B	5.37B
Long-term Investments	170M	239M	284M	295M	295M
Goodwill	19.28M	19.28M	19.28M	19.28M	19.28M
Other Intangibles, Total	271M	343M	353M	318M	300M
Deferred Tax Assets Long-Term	124M	115M	186M	569M	928M
Deferred Charges Long-Term	403M	485M	732M	1.09B	1.51B
Other Long-Term Assets, Total	305M	535M	323M	308M	188M
Total Assets	15.22B	30.05B	38B	50.23B	49.91B
Liabilities
Accounts Payable, Total	3.08B	9.18B	9.81B	13.14B	5.42B
Accrued Expenses, Total	503M	1.09B	1.24B	1.67B	867M
Short-term Borrowings	2.87B	569M	1.78B	2.64B	11.9B
Current Portion of Long-Term Debt	-	-	-	36.41M	83.83M
Current Portion of Leases	-	248K	9.81M	10.2M	9.81M
Current Income Taxes Payable	324M	933M	348M	435M	80.33M
Unearned Revenue Current, Total	-	-	-	11.31M	11.87M
Other Current Liabilities	31.91M	99.62M	40.17M	144M	67.03M
Total Current Liabilities	6.82B	11.87B	13.23B	18.09B	18.44B
Long-Term Debt	-	236M	211M	328M	348M
Long-Term Leases	-	12.24M	27.76M	25.31M	15.45M
Unearned Revenue Non Current	116M	222M	238M	228M	230M
Deferred Tax Liability Non Current	29.88M	48.34M	60.77M	57.96M	44.31M
Other Non Current Liabilities	4.35M	-	-	-	-
Total Liabilities	6.97B	12.39B	13.77B	18.73B	19.08B
Common Stock, Total	1.6B	1.6B	1.6B	2.4B	2.39B
Additional Paid In Capital	208M	208M	208M	47.96M	-
Retained Earnings	6.44B	15.85B	22.43B	29.06B	28.44B
Treasury Stock	-	-	-	-	-
Total Common Equity	8.25B	17.66B	24.24B	31.51B	30.83B
Total Equity	8.25B	17.66B	24.24B	31.51B	30.83B
Total Liabilities And Equity	15.22B	30.05B	38B	50.23B	49.91B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.4B	2.4B	2.4B	2.4B	2.39B
ECS Total Common Shares Outstanding	2.4B	2.4B	2.4B	2.4B	2.39B
Book Value / Share	3.44	7.36	10.1	13.13	12.88
Tangible Book Value	7.96B	17.3B	23.86B	31.17B	30.51B
Tangible Book Value Per Share	3.32	7.21	9.94	12.99	12.75
Total Debt	2.87B	818M	2.03B	3.04B	12.36B
Net Debt	1.44B	-3.49B	-589M	-3.31B	9.66B
Debt Equivalent Oper. Leases	49.13M	70.46M	74.77M	602M	629M
Equity Method Investments, Total	-	-	-	-	30M
Account Code - Inventory Valuation	6	6	6	6	8
Inventories - Raw Materials, Total	91.98M	248M	239M	178M	174M
Inventories - Work In Process, Total	69.82M	200M	203M	174M	166M
Inventories - Finished Goods, Total	3.24B	7.02B	7.59B	-	21.93B
Inventories - Others	-	-	-	8.79B	-
Buildings, Total	1.01B	1.04B	1.71B	2.52B	2.63B
Machinery, Total	905M	1.37B	2.06B	2.53B	3.33B
Full Time Employees	3.38K	4.8K	5.74K	6.54K	7.22K
Accumulated Allowance for Doubtful Accounts (Supple)	249M	439M	859M	1.21B	1.82B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	3.3B	10.21B	7.54B	8.07B	2.02B
Depreciation & Amortization - CF	107M	264M	275M	303M	361M
Amortization of Goodwill and Intangible Assets - (CF)	13.23M	111M	38.57M	17.87M	23.84M
Depreciation & Amortization, Total	120M	375M	313M	321M	385M
Amortization of Deferred Charges, Total - (CF)	11.05M	14.15M	17.73M	17.65M	19.75M
(Gain) Loss From Sale Of Asset	-19.65K	-39.13K	-6.69K	-41.37M	-46.95K
(Gain) Loss on Sale of Investments - (CF)	-	20.03M	-	-	-
Asset Writedown & Restructuring Costs	549K	1.68M	92.8K	129K	362K
Provision and Write-off of Bad Debts	82.93M	191M	421M	353M	609M
Other Operating Activities, Total	184M	134M	166M	394M	188M
Change In Accounts Receivable	-2.25B	-6.55B	-8.06B	-6.76B	10.17B
Change In Inventories	-975M	-3.98B	-766M	-1.31B	-13.25B
Change In Accounts Payable	3.06B	8.06B	2.41B	8.34B	-4.18B
Change In Deferred Taxes	-44.52M	27.28M	-58.31M	-386M	-373M
Cash from Operations	3.5B	8.51B	1.99B	9B	-4.41B
Capital Expenditure	-827M	-1.93B	-1.45B	-1.13B	-930M
Sale of Property, Plant, and Equipment	101K	325K	647K	168M	4.76M
Investment in Marketable and Equity Securities, Total	-70M	-69M	-45.5M	-10.5M	-
Other Investing Activities, Total	-	-18.55M	-	-	-
Cash from Investing	-897M	-2.02B	-1.5B	-977M	-926M
Short Term Debt Issued, Total	6.65B	94.63M	39.08M	5.54M	1.16M
Long-Term Debt Issued, Total	-	2.57B	5.48B	6.34B	14.74B
Total Debt Issued	6.65B	2.66B	5.52B	6.35B	14.74B
Short Term Debt Repaid, Total	-8.03B	-75.01M	-18.64M	-390K	-1.55M
Long-Term Debt Repaid, Total	-	-5.31B	-6.64B	-9.74B	-10.2B
Total Debt Repaid	-8.03B	-5.39B	-6.66B	-9.74B	-10.2B
Repurchase of Common Stock	-	-	-	-	-300M
Common Dividends Paid	-929M	-862M	-1.01B	-889M	-2.53B
Common & Preferred Stock Dividends Paid	-929M	-862M	-1.01B	-889M	-2.53B
Other Financing Activities, Total	195M	-4.76M	-12.82M	-13.08M	-13.52M
Cash from Financing	-2.11B	-3.59B	-2.17B	-4.29B	1.7B
Foreign Exchange Rate Adjustments	-4.93M	-9.66M	17.56M	-2.3M	1.25M
Net Change in Cash	481M	2.89B	-1.66B	3.72B	-3.64B
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	875M	1.95B	3.27B	3.31B	2.07B
Levered Free Cash Flow	-96.68M	2.89B	-3.93B	1.49B	-10.53B
Unlevered Free Cash Flow	-17.22M	2.92B	-3.9B	1.54B	-10.44B
Change In Net Working Capital	1.83B	2.99B	8.21B	3.41B	11.38B
Net Debt Issued / Repaid	-1.38B	-2.72B	-1.14B	-3.39B	4.54B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	19.17	32.93	15.98	13.04	2.92
Return on Total Capital	26.04	50.36	24.3	18.92	3.76
Return On Equity %	47.18	78.81	35.99	28.95	6.48
Return on Common Equity	47.18	78.81	35.99	28.95	6.48
Margin Analysis
Gross Profit Margin %	38.67	48.73	33.31	26.31	27.23
SG&A Margin	9.28	6.97	6.78	5.96	11.68
EBITDA Margin %	27.2	40.11	23.52	17.98	10.4
EBITA Margin %	26.49	39.26	22.83	17.43	9.06
EBIT Margin %	26.41	38.9	22.73	17.4	8.97
Income From Continuing Operations Margin %	21.73	33.3	19.7	15.25	7.74
Net Income Margin %	21.73	33.3	19.7	15.25	7.74
Net Avail. For Common Margin %	21.73	33.3	19.7	15.25	7.74
Normalized Net Income Margin	15.97	24.27	14.18	10.82	5.33
Levered Free Cash Flow Margin	-0.64	9.42	-10.27	2.82	-40.41
Unlevered Free Cash Flow Margin	-0.11	9.53	-10.19	2.92	-40.06
Asset Turnover
Asset Turnover	1.16	1.35	1.12	1.2	0.52
Fixed Assets Turnover	6.95	10.31	9.28	10.78	4.97
Receivables Turnover (Average Receivables)	2.74	3.14	2.29	2.22	1.19
Inventory Turnover (Average Inventory)	3.16	2.91	3.31	4.59	1.22
Short Term Liquidity
Current Ratio	1.69	2.09	2.37	2.35	2.24
Quick Ratio	1.18	1.45	1.76	1.85	1.03
Operating Cash Flow to Current Liabilities	0.51	0.72	0.15	0.5	-0.24
Days Sales Outstanding (Average Receivables)	133.56	116.14	159.71	164.42	306.8
Days Outstanding Inventory (Average Inventory)	115.7	125.32	110.18	79.59	301
Average Days Payable Outstanding	94.87	113.64	132.48	104.8	105.48
Cash Conversion Cycle (Average Days)	154.4	127.83	137.4	139.21	502.32
Long Term Solvency
Total Debt/Equity	34.84	4.63	8.39	9.63	40.09
Total Debt / Total Capital	25.84	4.43	7.74	8.79	28.61
LT Debt/Equity	-	1.41	0.98	1.12	1.18
Long-Term Debt / Total Capital	-	1.35	0.91	1.02	0.84
Total Liabilities / Total Assets	45.79	41.24	36.23	37.28	38.23
EBIT / Interest Expense	31.55	212.39	163.21	113.66	15.92
EBITDA / Interest Expense	32.5	219.06	169.08	117.62	18.54
(EBITDA - Capex) / Interest Expense	25.99	184.65	141.82	103.62	12.21
Total Debt / EBITDA	0.7	0.07	0.23	0.32	4.54
Net Debt / EBITDA	0.35	-0.28	-0.07	-0.35	3.55
Total Debt / (EBITDA - Capex)	0.87	0.08	0.27	0.36	6.89
Net Debt / (EBITDA - Capex)	0.43	-0.34	-0.08	-0.39	5.39
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	43.48	101.79	24.83	38.3	-50.74
Gross Profit, 1 Yr. Growth %	32.51	154.28	-14.6	9.22	-49.05
EBITDA, 1 Yr. Growth %	39.84	197.56	-26.8	5.68	-71.53
EBITA, 1 Yr. Growth %	39.82	199.01	-27.41	5.55	-74.4
EBIT, 1 Yr. Growth %	39.96	197.28	-27.06	5.84	-74.61
Earnings From Cont. Operations, 1 Yr. Growth %	39.51	209.23	-26.15	7.04	-74.99
Net Income, 1 Yr. Growth %	39.51	209.23	-26.15	7.04	-74.99
Normalized Net Income, 1 Yr. Growth %	39.02	206.74	-27.04	5.47	-75.74
Diluted EPS Before Extra, 1 Yr. Growth %	39.5	209.23	-26.15	7.04	-74.94
Accounts Receivable, 1 Yr. Growth %	49.28	94.25	60.2	31.26	-39.86
Inventory, 1 Yr. Growth %	37.07	116.86	8.6	12.04	147.25
Net Property, Plant and Equip., 1 Yr. Growth %	20.3	49.04	31.94	9.1	4.89
Total Assets, 1 Yr. Growth %	39.05	97.48	26.48	32.18	-0.64
Tangible Book Value, 1 Yr. Growth %	45.04	117.31	37.98	30.61	-2.11
Common Equity, 1 Yr. Growth %	43.52	114.06	37.26	30	-2.14
Cash From Operations, 1 Yr. Growth %	155.79	143.3	-76.62	352.3	-149.06
Capital Expenditures, 1 Yr. Growth %	44.34	133.63	-24.79	-21.95	-17.97
Levered Free Cash Flow, 1 Yr. Growth %	-91.43	-3.09K	-236.15	-138.01	-804.97
Unlevered Free Cash Flow, 1 Yr. Growth %	-98.41	-17.08K	-233.37	-139.64	-775.92
Dividend Per Share, 1 Yr. Growth %	0	20.01	-16.68	140.02	-75
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	70.45	70.15	58.71	31.39	-17.46
Gross Profit, 2 Yr. CAGR %	43.65	83.56	47.3	-3.42	-25.37
EBITDA, 2 Yr. CAGR %	51.32	104	47.59	-12.04	-45.13
EBITA, 2 Yr. CAGR %	52.38	104.48	47.33	-12.46	-48.01
EBIT, 2 Yr. CAGR %	52.74	103.98	47.26	-12.13	-48.16
Earnings From Cont. Operations, 2 Yr. CAGR %	50.82	107.7	51.12	-11.09	-48.26
Net Income, 2 Yr. CAGR %	50.82	107.7	51.12	-11.09	-48.26
Normalized Net Income, 2 Yr. CAGR %	51.02	106.5	49.6	-12.28	-49.42
Diluted EPS Before Extra, 2 Yr. CAGR %	50.82	107.7	51.12	-11.09	-48.2
Accounts Receivable, 2 Yr. CAGR %	83.06	70.29	76.41	45.01	-11.15
Inventory, 2 Yr. CAGR %	38.15	72.41	53.46	10.31	66.44
Net Property, Plant and Equip., 2 Yr. CAGR %	25.09	33.9	40.23	19.98	6.97
Total Assets, 2 Yr. CAGR %	49.47	65.71	58.04	29.3	14.6
Tangible Book Value, 2 Yr. CAGR %	42.68	77.54	73.16	34.25	13.07
Common Equity, 2 Yr. CAGR %	40.46	75.28	71.41	33.58	12.79
Cash From Operations, 2 Yr. CAGR %	144.36	149.47	-24.58	2.83	48.97
Capital Expenditures, 2 Yr. CAGR %	31.28	83.64	32.56	-23.38	-19.98
Levered Free Cash Flow, 2 Yr. CAGR %	-61.71	59.94	537.66	-28.06	63.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	-83.63	64.42	1.4K	-27.29	63.68
Dividend Per Share, 2 Yr. CAGR %	0	9.55	0	41.42	-22.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	124.5	80.32	53.46	51.59	-5.25
Gross Profit, 3 Yr. CAGR %	79.22	73.77	42.19	33.32	-21.94
EBITDA, 3 Yr. CAGR %	95.38	89.59	44.97	32.05	-39.6
EBITA, 3 Yr. CAGR %	99.6	90.78	44.79	31.84	-41.89
EBIT, 3 Yr. CAGR %	101.1	90.7	44.78	31.91	-41.91
Earnings From Cont. Operations, 3 Yr. CAGR %	96.93	91.6	47.14	34.71	-41.74
Net Income, 3 Yr. CAGR %	96.93	91.6	47.14	34.71	-41.74
Normalized Net Income, 3 Yr. CAGR %	97.29	91.26	45.99	33.14	-42.85
Diluted EPS Before Extra, 3 Yr. CAGR %	96.93	91.6	47.14	34.71	-41.7
Accounts Receivable, 3 Yr. CAGR %	111.45	86.72	66.86	59.85	8.14
Inventory, 3 Yr. CAGR %	75.72	60.56	47.79	38.18	44.36
Net Property, Plant and Equip., 3 Yr. CAGR %	23.63	32.62	33.25	28.97	14.72
Total Assets, 3 Yr. CAGR %	54.75	64.01	51.44	48.9	18.43
Tangible Book Value, 3 Yr. CAGR %	43.09	64.16	63.23	57.62	20.83
Common Equity, 3 Yr. CAGR %	41.08	61.64	61.56	56.32	20.42
Cash From Operations, 3 Yr. CAGR %	158	144.01	13.32	37.03	-19.65
Capital Expenditures, 3 Yr. CAGR %	53.01	59.09	36.37	11.1	-21.62
Levered Free Cash Flow, 3 Yr. CAGR %	3.74	63.6	51.58	149.1	53.95
Unlevered Free Cash Flow, 3 Yr. CAGR %	-40.5	65.69	53.34	347.71	52.88
Dividend Per Share, 3 Yr. CAGR %	56.65	6.27	0	33.89	-20.63
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	84.39	133.04	95.42	58.87	19.75
Gross Profit, 5 Yr. CAGR %	59.56	107.7	65.69	37.36	9.87
EBITDA, 5 Yr. CAGR %	77.96	185.07	74.65	39.45	-1.71
EBITA, 5 Yr. CAGR %	81.76	248.71	76.78	39.71	-3.88
EBIT, 5 Yr. CAGR %	83.89	303.77	77.53	39.87	-3.99
Earnings From Cont. Operations, 5 Yr. CAGR %	75.66	215.76	77.14	40.93	-3.13
Net Income, 5 Yr. CAGR %	75.66	215.76	77.14	40.93	-3.13
Normalized Net Income, 5 Yr. CAGR %	77.56	218.42	76.61	40.03	-4.46
Diluted EPS Before Extra, 5 Yr. CAGR %	76.63	216.94	77.14	40.94	-3.09
Accounts Receivable, 5 Yr. CAGR %	83.16	112.07	96.67	68.76	29.68
Inventory, 5 Yr. CAGR %	99.43	134.37	66.45	38.17	54.99
Net Property, Plant and Equip., 5 Yr. CAGR %	21.14	26.24	30.02	27.41	22.04
Total Assets, 5 Yr. CAGR %	41.51	61.8	56.06	49.13	35.46
Tangible Book Value, 5 Yr. CAGR %	28.96	49.85	54.43	51.47	40.94
Common Equity, 5 Yr. CAGR %	27.28	47.59	52.51	49.77	39.93
Cash From Operations, 5 Yr. CAGR %	73.34	148.4	57.75	72.7	26.42
Capital Expenditures, 5 Yr. CAGR %	29.65	44.37	44.48	18.77	10.18
Levered Free Cash Flow, 5 Yr. CAGR %	38.36	70.78	114.49	17.78	56.32
Unlevered Free Cash Flow, 5 Yr. CAGR %	-2.02	71.19	116.61	19.18	57.39
Dividend Per Share, 5 Yr. CAGR %	58.42	126.57	30.91	19.14	-9.71